Acadia Healthcare Company Inc. Common Stock (ACHC)

FairStock Score: 42/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach Acadia as a potential turnaround, not a compounder. It provides behavioral healthcare through acute psychiatric facilities, specialty treatment and outpatient clinics, with 25,000 employees. That scale and licensed psychiatric capacity can create local barriers, but this is not a wide-moat business; reimbursement and regulation drive economics. The filed numbers show the problem. In fiscal 2024, ended 2024-12-31, the company earned $255.6M, or $2.78 per diluted share, on revenue of $3.2B. In fiscal 2025, ended 2025-12-31, revenue was $3.3B but net income was -$1.1B and diluted EPS -$12.16, largely because the fiscal Q4 2025 quarter ended 2025-12-31 produced a $1.2B net loss. Since then, fiscal Q1 2026, ended 2026-03-31, showed revenue of $828.8M and net income of $4.1M, or $0.05 per diluted share—barely profitable. Earlier quarters were better: fiscal Q3 2025, ended 2025-09-30, had net income of $36.2M; fiscal Q2 2025, ended 2025-06-30, had $30.1M. Financial health is strained: FairStock's figures show debt-to-equity of 1.18, ROCE of 3.57%, trailing free cash flow of -$134.0M, a -4.8% FCF yield, and an Altman Z-Score of 0.58. Revenue growth was -0.39% and profit growth -63.73%. At the 2026-10-13 close of $30.23, the market cap is $2.8B; FairStock shows P/B 1.39 and P/E -2.43. The 42/100 FairStock Score and Lynch turnaround label capture the uncertainty. A Piotroski F-Score of 7/9 offers some hope, but I would need evidence that cash flow and margins are recovering before calling this cheap rather than distressed.

In plain English: Acadia Healthcare runs psychiatric hospitals and addiction treatment centers. The business has looked weak lately: it lost $1.1B in fiscal 2025 after earning $255.6M in fiscal 2024, and it burned cash over the past year. At the 2026-10-13 price of $30.23, the stock may look inexpensive compared with the value of its assets on the books, but the earnings record makes it a risky turnaround rather than a clear bargain.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q4 2025 10-Q (period ended 2025-12-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer